FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
32
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:23
WFTX
11 months agoMarco Patriots headed home after helping people impacted by Idalia
628 -
0:42
KMGH
2 years agoBBB warns about travel scams
49 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
52 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:37:17
Kim Iversen
12 hours agoAbortion Activists Go Wild at the DNC: Abortion Pills & Free Vasectomies on Display
95.5K131 -
26:31
Michael Franzese
11 hours agoJoe Rogan doesn't HOLD BACK in Netflix Special
77.1K46 -
1:36:32
Glenn Greenwald
12 hours agoIs Kamala Harris "Working Tirelessly" for a Cease-Fire in Gaza?; Jonathan Turley on Free Speech; Richard Medhurst on his UK Arrest | System Update #318
124K115